RI H7921

Licensed pharmacists may independently test for and treat influenza, COVID-19, strep throat, and post-exposure prophylaxis for STIs using CLIA-waived tests and statewide protocols adopted by the Board of Pharmacy

Pharmacists must complete board-established education requirements before providing test-and-treat services and document each encounter, with notification to the patient's primary care provider within 7 business days upon patient consent

State-regulated health insurance plans, Medicaid, nonprofit hospital/medical service corporations, and HMOs must cover pharmacist test-and-treat services at parity with physicians, nurse practitioners, and physician assistants starting January 1, 2027

Health plans must include pharmacists in their medical provider networks separately from pharmacy drug benefit networks and cannot require physician supervision or referral for reimbursement

The Board of Pharmacy must promulgate implementing rules within 6 months of the effective date and may authorize additional conditions for test-and-treat services based on safety, evidence, and public health needs